Brief: Lyell Immunopharma Reports Second Quarter Financial Results And Business Highlights
04/08/2022 22:42
Aug 4 (Reuters) - Lyell Immunopharma Inc LYEL.O :
* LYELL IMMUNOPHARMA REPORTS SECOND QUARTER FINANCIAL
RESULTS AND
BUSINESS HIGHLIGHTS
* LYELL IMMUNOPHARMA INC- REVENUE WAS $35.7 MILLION AND $2.6
MILLION FOR THREE MONTHS ENDED JUNE 30, 2022 AND 2021,
RESPECTIVELY
Source text for Eikon: ID:nGNX59q8WP
Further company coverage: LYEL.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Lyell Immunopharma
See all newsBrief: Lyell Immunopharma Says Additional Clinical Data And End-Of-Phase 1 FDA Meeting Expected In 2027
Lyell Immunopharma, Inc. reports results for the quarter ended June 30 - Earnings Summary
Lyell Immunopharma, Inc. expected to post a loss of $2.08 a share - Earnings Preview
Brief: Lyell Immunopharma Q2 Operating Expenses USD 47.341 Million
Brief: Lyell Immunopharma Shows Updated Safety Data For Ronde-Cel In Patients With Large B-Cell Lymphoma